NODAL MARGINAL ZONE LYMPHOMA
Clinical trials for NODAL MARGINAL ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NODAL MARGINAL ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for NODAL MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to wipe out Early-Stage lymphoma
Disease control Recruiting nowThis study is testing an investigational drug called epcoritamab in adults who have just been diagnosed with marginal zone lymphoma (MZL) and have not yet received any treatment. The main goal is to see how many participants achieve a complete response, meaning no detectable canc…
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Izidore Lossos, MD • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New pill tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new oral drug called SGR-1505 in adults with various types of relapsed or hard-to-treat B-cell cancers, like non-Hodgkin lymphoma and chronic lymphocytic leukemia. The main goal is to find the highest dose patients can tolera…
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New 'Living Drug' trial targets advanced blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for adults with certain blood cancers that have returned or not responded to standard treatments. Doctors modify a patient's own immune cells (T cells) in a lab to better recognize and attack cancer cells, then infuse t…
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Scientists dig into old lymphoma samples to find hidden clues
Knowledge-focused Recruiting nowThis study aims to improve how doctors understand and predict outcomes for a rare type of lymphoma called Nodal Marginal Zone Lymphoma (NMZL). Researchers will analyze stored tumor samples and medical records from 300 past patients to identify molecular patterns. The goal is to l…
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC